Biotechnology Stocks

Biotechnology stocks are firms that are active in the sector and publicly traded. Biotechnology companies use applied biology for advancements in current methodologies in a variety of industries. The field uses living organisms and bio-processes in many sectors, such as medicine, engineering, agriculture and technology. Since there is a lot of research and development in this sector, small biotech stocks that can develop a new advancement in technology can become very wealthy firms and the stock price can move up sharply. Biotechnology stocks raise money in the public market to help fund this research.


3 Top Biotech Stocks to Watch in 2015

By Tuesday, September 1, 2015
Biotech StocksBefore Black Friday, the biotech industry was seriously outperforming the S&P 500. In fact, aside from a solid correction in early 2014 (which it subsequently topped a few months later), the biotech sector has been one of the bright spots in 2015. The iShares Nasdaq Biotechnology (NASDAQ:IBB) ETF climbed 25% between January 1st.

Biotech Stocks to Watch in May 2015

By Tuesday, May 5, 2015
biotech stocks to watchThe best biotech stocks to watch for in May 2015 are businesses that dominate their respective market, command a diverse drug pipeline, and have lots of profits to show for it. Profitability is crucial given that the NASDAQ Biotechnology Index continues to climb higher, gaining 12% in 2015 and adding to the 36% increase in 2014. Biotech.

Two Large-Cap Biotech Stocks for a Slow-Growth Market

By Monday, May 4, 2015
Biotech Stocks to watchThe main market indices remain in consolidation, with the more speculative averages like the Russell 2000 and NASDAQ Biotechnology Index now experiencing a bit of a price retrenchment. However, biotech stocks are still the place to be if you’re looking for a lot of growth. Among risk-capital sectors of the equity market, biotech .

Top Biotech Stocks to Watch in 2015: What’s Trending in 2015

By Friday, March 27, 2015
Top Biotech Stocks to watchIn searching for the top biotech stocks to watch in 2015, let’s not forget that many on Wall Street are talking about the group’s sky-high valuations. In fact, since the start of 2012, the NASDAQ Biotechnology index has gained 256%. In the same period, the S&P 500 has only mustered a 65% gain. With that in mind, it’s important .

Biotech Stocks Showing Strength Among Speculative Market Action

By Friday, March 6, 2015
Biotech Stocks Showing StrengthWith indecisive stock market action, biotechnology stocks continue to show their speculative strength. It’s a market sector that continues to be very strong, albeit highly speculative. Of course, where there’s growth, there are also higher valuations and many of the large-cap biotechnology and pharmaceutical companies are.
Sep. 5, 2015
Trailing 12-month EPS for Dow Jones companies (Most Recent Quarter) $1014.15
Trailing 12-month Price/earnings multiple (Most Recent Quarter)

17.44

Dow Jones Industrial Average Dividend Yield 2.62%
10-year U.S. Treasury Yield 2.19%

Immediate term outlook:
The bear market rally in stocks that started in March 2009, extended because of unprecedented central bank money printing, is coming to an end. Gold bullion is up $1,000 an ounce since we first recommended it in 2002 and we are still bullish on the physical metal.

Short-to-medium term outlook:
World economies are entering their slowest growth period since 2009. The Chinese economy grew last year at its slowest pace in 24 years. Japan is in recession. The eurozone is in depression. With almost half the S&P 500 companies deriving revenue outside the U.S., slower world economic growth will negatively impact revenue and earnings growth of American companies. Domestically, America’s gross domestic product grew by only a meager 2.3% in the second quarter, which will negatively impact an already overpriced equity market.

Poll

For the rest of 2015, what's your take on the stock market?

View Results

Loading ... Loading ...
×
From: Michael Lombardi, MBA
Subject: Gold: The Stock Contrarian Investors’ Best Play of the Decade

Read this message